In patients with T2D, when analyzed separately, semaglutide and tirzepatide were associated with a greater reduction of HbA1c and FPG compared to other agents, producing a T2D remission (discontinuing pharmacological treatment) in a relevant proportion of cases
The semaglutide group reduced 14.9% from their baseline body weight compared to 2.4% with the placebo group
This study provides a more solid scientific basis for the previous observational studies, and reveals the significance of retinol for diagnosis and monitoring the process on AD
The Use of Tranexamic Acid in Dermatology
Still, a large-scale French study did find a potential link between GLP-1 use and thyroid cancer, especially in patients who used the drug for more than a year
Trajectory of weight regain after cessation of GLP-1 receptor agonists: A systematic review and nonlinear meta-regression